Vanda Pharmaceuticals Inc (VNDA) — Strategic Asset Allocation Index
Vanda Pharmaceuticals Inc (VNDA) has a Strategic Asset Allocation Index of 0.4% as of June 2023. Strategic assets (PP&E of $2.16 Million plus long-term investments of $-) total $2.16 Million, measured against net assets of $539.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See VNDA equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Vanda Pharmaceuticals Inc Strategic Asset Allocation Index (2004–2022)
This chart shows how Vanda Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 19 annual periods from 2004 to 2022. As of June 2023, the index stands at 0.4%, representing strategic assets of $2.16 Million against net assets of $539.90 Million USD. For live market cap and overall valuation, see Vanda Pharmaceuticals Inc stock valuation.
Annual Strategic Asset Allocation Index for Vanda Pharmaceuticals Inc (2004–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Vanda Pharmaceuticals Inc from 2004 to 2022, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Vanda Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.5% | $2.57 Million | $2.57 Million | $- | $527.20 Million | ▼ -2.0 pp |
| 2021 | 2.5% | $12.38 Million | $12.38 Million | $- | $504.93 Million | ▲ +1.5 pp |
| 2020 | 0.9% | $4.14 Million | $4.14 Million | $- | $453.27 Million | ▼ 0.0 pp |
| 2019 | 0.9% | $3.86 Million | $3.86 Million | $- | $410.94 Million | ▼ -0.7 pp |
| 2018 | 1.6% | $4.42 Million | $4.42 Million | $- | $275.42 Million | ▼ -2.4 pp |
| 2017 | 4.0% | $5.31 Million | $5.31 Million | $- | $131.39 Million | ▲ +0.2 pp |
| 2016 | 3.8% | $5.01 Million | $5.01 Million | $- | $131.33 Million | ▲ +0.4 pp |
| 2015 | 3.4% | $4.57 Million | $4.57 Million | $- | $133.03 Million | ▲ +1.9 pp |
| 2014 | 1.5% | $2.44 Million | $2.44 Million | $- | $160.82 Million | ▼ -3.5 pp |
| 2013 | 5.0% | $2.20 Million | $2.20 Million | $- | $44.12 Million | ▼ -18.7 pp |
| 2012 | 23.7% | $2.35 Million | $2.35 Million | $- | $9.90 Million | ▼ -36.0 pp |
| 2011 | 59.7% | $19.98 Million | $964.00K | $19.01 Million | $33.47 Million | ▲ +57.2 pp |
| 2010 | 2.5% | $937.00K | $937.00K | $- | $37.73 Million | ▼ -3.2 pp |
| 2009 | 5.7% | $1.32 Million | $1.32 Million | $- | $23.03 Million | ▲ +1.9 pp |
| 2008 | 3.8% | $1.76 Million | $1.76 Million | $- | $46.02 Million | ▲ +2.2 pp |
| 2007 | 1.6% | $1.35 Million | $1.35 Million | $- | $83.73 Million | ▼ -5.3 pp |
| 2006 | 7.0% | $1.86 Million | $1.86 Million | $- | $26.76 Million | ▲ +3.3 pp |
| 2005 | 3.6% | $1.11 Million | $1.11 Million | $- | $30.66 Million | ▼ -4.2 pp |
| 2004 | 7.9% | $1.25 Million | $1.25 Million | $- | $15.94 Million | — |